Pharmacokinetics and Tolerance of Meloxicam Eye Drops in Healthy Volunteers, a Phase I , Single-dose and Multiple-dose, Open-labeled Clinical Trial
Latest Information Update: 09 Apr 2022
At a glance
- Drugs Meloxicam (Primary)
- Indications Ankylosing spondylitis; Back pain; Cataracts; Gout; Juvenile rheumatoid arthritis; Neuropathic pain; Ocular inflammation; Osteoarthritis; Periarthritis; Rheumatoid arthritis
- Focus Pharmacokinetics; Therapeutic Use
Most Recent Events
- 30 Mar 2020 New trial record